These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 382530)

  • 1. Effects of different ATG (ATGAM) regimens on levels of rosette-forming cells (RFC), serum horse IgG (HoI), and anti-horse antibodies in kidney transplant patients.
    Satoh P; Elberg A; Davis J; Uittenbogaart C; Fine R; Hardy MA
    Transplant Proc; 1979 Jun; 11(2):1427-8. PubMed ID: 382530
    [No Abstract]   [Full Text] [Related]  

  • 2. Does suppression of T-RFC determine in vivo immunosuppressive effect of ATG?
    Geis WP; Giacchino JL; Buckingham JM; Bansal VK; Iwatsuki S; Kerman RH; Ing TS; Hano JE
    Transplant Proc; 1979 Jun; 11(2):1433-4. PubMed ID: 382533
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of anti-lymphocyte globulin on lymphocyte subpopulations in recipients of kidney allografts.
    Ringdén O; Quadracci LJ; Groth CG
    Scand J Urol Nephrol Suppl; 1977; (42):86-9. PubMed ID: 356231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active T and EA-rosette-forming cells in human cadaver renal allograft recipients.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1979 Feb; 35(2):236-41. PubMed ID: 373936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of antithymocyte globulin (dose by rosette protocol) in pediatric renal allograft recipients.
    Uittenbogaart CH; Robinson BJ; Malekzadeh MH; Pennisi AJ; Ettenger RB; Fine RN
    Transplantation; 1979 Oct; 28(4):291-3. PubMed ID: 388761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithymocyte globulin (ATG) dosage and graft survival in renal transplantation.
    Kountz SL; Butt KH; Rao TK; Zielinski CM; Rafi M; Schultz JR
    Transplant Proc; 1977 Mar; 9(1):1023-5. PubMed ID: 325728
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in peripheral blood T-cell rosettes in kidney allograft patients during the first postoperative month.
    Daudu P; Wright K; Geelhoed GW
    Am Surg; 1980 Dec; 46(12):697-707. PubMed ID: 7004286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of horse ATG and rabbit ATG on T cell and T cell subset levels measured by monoclonal antibodies.
    Thomas FT; Griesedieck C; Thomas J; Carver M; Whitley T; Warren R; Williams D
    Transplant Proc; 1984 Dec; 16(6):1561-3. PubMed ID: 6239426
    [No Abstract]   [Full Text] [Related]  

  • 9. Antilymphocytic antibodies and marrow transplantation: ATG suppresses antiantibody formation against monoclonal anti-T-cell antibodies.
    Thierfelder S; Kremmer E; Lederer R; Kummer U
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3055-7. PubMed ID: 2650423
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of circulating rosette-forming cells as a guide to determination of ATG dose (dose-by-rosette).
    Byfield PE; Barth CL; Brodie JA; Cosimi AB; Dienst SG; Elberg AJ; Elfring GL; Hardy MA; Hayashi H; Kountz SL; Lamborn KR; Loughman BE; Sakai A; Satoh PS; Zielinski CM; Wechter WJ
    Transplant Proc; 1978 Sep; 10(3):627-31. PubMed ID: 362648
    [No Abstract]   [Full Text] [Related]  

  • 11. Individualized monitoring and modulation of immune reactivity using standardized antithymocyte globulin (ATG).
    Thomas F; Mendez-Picon G; Thomas J; Lee HM
    Transplant Proc; 1979 Jun; 11(2):1429-30. PubMed ID: 382531
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo - in vitro correlates of antithymocyte globulin (ATG) immunosuppression in the human.
    Thomas F; Berry R; Mendez-Picon G; Thomas J; Lower RR; Lee HM
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():56-61. PubMed ID: 386321
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of an antiglobulin-ATG reagent for detection of low levels of alloantibody-improvement of allograft survival in presensitized recipients.
    Fuller TC; Cosimi AB; Russell PS
    Transplant Proc; 1978 Jun; 10(2):463-6. PubMed ID: 354136
    [No Abstract]   [Full Text] [Related]  

  • 14. Different reconstitution of peripheral blood lymphocytes and dendritic cells in liver and kidney transplant patients.
    Rondelli D; Abbasian J; Arpinati M; Panaro F; Porubsky M; Manzelli A; Oberholzer J; Benedetti E; Testa G
    Transplant Proc; 2005; 37(1):49-50. PubMed ID: 15808543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of anti-lymphocytic globulin in human subjects.
    Heyworth MF
    Immunology; 1981 Aug; 43(4):793-802. PubMed ID: 6974131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithymocyte globulin therapy after renal transplantation at the Massachusetts General Hospital.
    Delmonico FL
    Transplant Proc; 1984 Aug; 16(4):979-82. PubMed ID: 6380062
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic monitoring parameters in ALG- versus non-ALG-treated renal transplant patients.
    McAlack RF; Stern S; Beizer R; Sklar L; Bannett A
    Transplant Proc; 1979 Jun; 11(2):1431-2. PubMed ID: 382532
    [No Abstract]   [Full Text] [Related]  

  • 18. Randomized clinical trial of antithymocyte globulin induction in renal transplantation comparing a fixed daily dose with dose adjustment according to T cell monitoring.
    Abouna GM; al-Abdullah IH; Kelly-Sullivan D; Kumar MS; Loose J; Phillips K; Yost S; Seirka D
    Transplantation; 1995 Jun; 59(11):1564-8. PubMed ID: 7778170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant T cell levels and renal allograft survival.
    Uittenbogaart CH; Robinson BJ; Malekzadeh MH; Pennisi AJ; Ettenger RB; Fine RN
    Proc Eur Dial Transplant Assoc; 1979; 16():449-53. PubMed ID: 398517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbamylcholine modulation of E-rosette formation. Effect of plasmapheresis in myasthenia gravis.
    Mizuno Y; Humphrey J; Dosch HM; Gelfand EW
    Clin Exp Immunol; 1982 Jul; 49(1):209-16. PubMed ID: 6982131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.